Erdinç ERCAN, Zeynep KABLAN, Serkan ERGÖZEN, Bülent ERDOĞAN

İdiopatik unilateral ani işitme kaybında hiperbarik oksijen tedavisi etkinliği

Amaç: Çalışmamızda medikal tedavi alan ani idiopatik işitme kayıplı hastalarda (AISNIK) hiperbarik oksijen tedavisinin (HBOT) etkinliği ve tedavi sonuçlarını etkileyebilecek değişkenlerin etkileri araştırılmıştır. Gereç ve Yöntem: Çalışmamızda 2013-2019 yılları arasında HBOT Merkezi’ne başvuran, son 30 gün içinde unilateral AISNIK tanısı odyolojik testle tespit edilmiş, HBOT ve medikal tedavi almış olan 18 yaş üstü hastaların dosyaları retrospektif olarak incelenmiştir. Yaş, cinsiyet, işitme kaybının derecesi ve semptomların başlangıç zamanından tedavinin başlangıcına kadar geçen süre değerlendirilmiştir. Tedavi öncesi ve tedavi sonrası saf ses ortalamaları bu değişkenlere göre karşılaştırılmıştır. Bulgular: 135 hastanın 70 (%51,86)’i kadın, 65 (%48,14)’i erkekti. İşitme kazancı, erkek hastalarda tüm yaş gruplarında, kadın hastalarda ise 18-39 ve 40-59 yaş gruplarında yüksek bulunmuştur. Erkek hasta grubunda tedavi öncesi şiddetli ve tam işitme kayıp gruplarındaki HBOT sonrası iyileşme kazançları yüksek bulunmuştur. Kadınlarda ise başlangıç işitme kaybı gruplarının tamamında tedavi sonrası gerçekleşen iyileşme kazançları yüksek saptanmıştır. Erkeklerde 14 güne kadar olan başvurularda işitme seviyelerinde saptanan kazanç istatistiksel olarak anlamlı bulunurken kadınlarda 30 güne kadar olan başvuruların tamamında işitme seviyelerinde saptanan kazanç anlamlı bulunmuştur. Sonuç: Bu çalışmada işitme kaybı yaşayan hastalarda HBOT etkinliği üzerine cinsiyetin etkisinin olmadığı, hasta yaşı ilerledikçe tedaviden elde edilen kazancın azaldığı, tedaviye erken başlamanın daha olumlu sonuçlandığı ve başlangıçta ileri düzey işitme kaybı olanların işitme kazançlarının daha fazla olduğu gösterilmiştir.

Anahtar Kelimeler:

Hiperbarik Oksijen Tedavisi, Ani İşitme Kaybı, HBOT

Efficacy of hyperbaric oxygen therapy in sudden unilateral idiopathic sensorineural hearing loss

Purpose: We investigated the effectiveness of hyperbaric oxygen therapy (HBOT) in patients receiving medical treatment with the diagnosis of sudden unilateral idiopathic sensorineural hearing loss (ISSNHL). Materials and Methods: The records of the patients referred to our hyperbaric oxygen therapy clinic between 2013 and 2019 were analyzed retrospectively. All patients’ age was over 18 years old, and ISSNHL was diagnosed in the last 30 days with pure tone audiometry. averages of pure tone results of the patients were compared before and after HBOT according to variables of age, gender, hearing loss level before the treatment, and elapsed time to the treatment. Results: A total of 135 patients were included, with 70 (51.86%) females and 65 (48.14%) males. The hearing gains were statistically significant in all age groups among males and statistically significant in 18-39 and 40-59 years old age groups among females. When cases were grouped according to elapsed time to HBOT, mean hearing gains of the 14-days group in males and both 14- and 30-days groups in females were statistically significant. Statistically significant hearing gains were detected in mild, moderate, moderate to severe, severe, and complete hearing loss groups in females, while only in moderate, severe, and complete hearing loss groups in males. Conclusion: Consequently, we think that earlier received HBOT with medical treatment applied to the younger adults with more severe disease gained more improvement in the hearing levels. Consequently, our findings showed that early administration of HBOT with MT resulted in better clinical improvements in the younger adults with severe ISSNHL.

Keywords:

Hyperbaric Oxygen Therapy, Sudden Hearing Loss, HBOT,

PDF

___

1. Van der Wal AW, Van Ooij PJAM, de Ru JA. Hyperbaric oxygen therapy for sudden sensorineural hearing loss in divers. J Laryngol Otol. 2015;130:1039- 47.
2. Rauch SD. Clinical practice: idiopathic sudden sensorineural hearing loss. N Engl J Med. 2008;359:833-40.
3. Edizer DT, Çelebi Ö, Hamit B, Baki A, Yigit O. Recovery of idiopathic sudden sensorineural hearing loss. J Int Adv Otol. 2015;11:122–6.
4. Chandrasekhar S, Tsai Do B, Schwartz S, Bontempo L, Faucett E, Finestone S et al. Clinical practice guideline: sudden hearing loss (Update). Otolaryngol Head Neck Surg. 2019;161:1–4.
5. Aslan I, Oysu C, Veyseller B, Baserer N. Does the addition of hyperbaric oxygen therapy to the conventional treatment modalities influence the outcome of sudden deafness? Otolaryngol Head Neck Surg. 2002;126:121–6.
6. Korpinar S, Alkan Z, Yigit O, Gör A, Toklu A, Cakir B et al. Factors influencing the outcome of idiopathic sudden sensorineural hearing loss treated with hyperbaric oxygen therapy. Eur Arch Otorhinolaryngol. 2011;268:41-47.
7. Topuz E, Yigit O, Cinar U, Seven H. Should hyperbaric oxygen be added to treatment in idiopathic sudden sensorineural hearing loss? Eur Arch Otorhinolaryngol. 2004;261:393–6.
8. Bayoumy AB, de Ru JA. The use of hyperbaric oxygen therapy in acute hearing loss: a narrative review. Eur Arch Otorhinolaryngol. 2019;276:1859-80.
9. Almosnino G, Holm JR, Schwartz SR, Zeitler DM. The role of hyperbaric oxygen as salvage therapy for sudden sensorineural hearing loss. Ann Otol Rhinol Laryngol. 2018;127:672–6.
10. Gulustan F, Yazici ZM, Alakhras WME, Erdur O, Acipayam H, Kufeciler L et al. Intratympanic steroid injection and hyperbaric oxygen therapy for the treatment of refractory sudden hearing loss. Braz J Otorhinolaryngol. 2018;84:28-33.
11. Tasdoven GE, Derin AT, Yaprak N, Ozcaglar HU. The place of hyperbaric oxygen therapy and ozone therapy in sudden hearing loss. Braz J Otorhinolaryngol. 2017;83:457-63.
12. Satar B, Hidir Y, Yetiser S. Effectiveness of hyperbaric oxygen therapy in idiopathic sudden hearing loss. J Laryngol Otol. 2006;120:665-9.
13. Cekin E, Cincik H, Ulubil SA, Gungor A. Effectiveness of hyperbaric oxygen therapy in management of sudden hearing loss. J Laryngol Otol. 2009;123:609–12.
14. Capuano L, Cavaliere M, Parente G, Damiano A, Pezzuti G, Lopardo D. Hyperbaric oxygen for idiopathic sudden hearing loss: is the routine application helpful? Acta Otolaryngol. 2015;135:692– 7.
15. Dundar K, Gumus T, Ay H, Yetiser S, Ertugrul E. Effectiveness of hyperbaric oxygen on sudden sensorineural hearing loss: prospective clinical research. J Otolaryngol. 2007;36:32–7.
16. Bayoumy AB, Van der Veen EL, Alexander de Ru J. Assessment of spontaneous recovery rates in patients with idiopathic sudden sensorineural hearing loss. JAMA Otolaryngol Head Neck Surg. 2018;144:655–6.
17. Fattori B, Berrettini S, Casani A, Nacci A, De Vito A, De Iaco G. Sudden hypoacusis treated with hyperbaric oxygen therapy: a controlled study. Ear Nose Throat J. 2001;80:655–60.
18. Hosokawa S, Sugiyama K, Takahashi G, Takebayashi S, Mineta H. Prognostic factors for idiopathic sudden sensorineural hearing loss treated with hyperbaric oxygen therapy and intravenous steroids. J Laryngol Otol. 2017;131:77–82.
19. Hosokawa S, Hosokawa K, Takahashi G, Sugiyama K, Nakanishi H, Takebayashi S et al. Hyperbaric oxygen therapy as concurrent treatment with systemic steroids for idiopathic sudden sensorineural hearing loss: a comparison of three different steroid treatments. Audiol Neurootol. 2018;23:145–51.
20. Yildirim E, Murat Ozcan K, Palali M, Cetin MA, Ensari S, Dere H. Prognostic effect of hyperbaric oxygen therapy starting time for sudden sensorineural hearing loss. Eur Arch Otorhinolaryngol. 2015;272:23–8.